Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the pharmacokinetics/pharmacodynamics and safety
of SHR3824 in Type 2 Diabetes Patients with Renal Insufficient.